ReviewDer Urologe. Ausg. A2010
[Diagnostic procedure for bladder cancer. Standards and current developments].
Review in Der Urologe. Ausg. A, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Raman spectroscopy for grading of live osteosarcoma cells.Stem cell research & therapy · 2015Article
- [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].Der Urologe. Ausg. A · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary cytology and white light endoscopy have been the gold standard for initial diagnosis of bladder cancer for decades. Furthermore the use of imaging techniques, such as ultrasound or CT scanning can be necessary in certain cases. This article gives an overview on standard diagnostic techniques and introduces new optical diagnostic technologies, such as Raman spectroscopy, optical coherence tomography, narrow band imaging and confocal laser microscopy, which could play a role in the diagnosis of bladder cancer in the future. Furthermore the current indications for photodynamic diagnoses are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.